Cite
Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [ 177 Lu]Lu-PSMA.
MLA
Hooijman, Eline L., et al. “Radiolabeling and Quality Control of Therapeutic Radiopharmaceuticals: Optimization, Clinical Implementation and Comparison of Radio-TLC/HPLC Analysis, Demonstrated by [ 177 Lu]Lu-PSMA.” EJNMMI Radiopharmacy and Chemistry, vol. 7, no. 1, Nov. 2022, p. 29. EBSCOhost, https://doi.org/10.1186/s41181-022-00181-0.
APA
Hooijman, E. L., Ntihabose, C. M., Reuvers, T. G. A., Nonnekens, J., Aalbersberg, E. A., van de Merbel, J. R. J. P., Huijmans, J. E., Koolen, S. L. W., Hendrikx, J. J. M. A., & de Blois, E. (2022). Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [ 177 Lu]Lu-PSMA. EJNMMI Radiopharmacy and Chemistry, 7(1), 29. https://doi.org/10.1186/s41181-022-00181-0
Chicago
Hooijman, Eline L, Carolline M Ntihabose, Thom G A Reuvers, Julie Nonnekens, Else A Aalbersberg, Jordy R J P van de Merbel, Judith E Huijmans, Stijn L W Koolen, Jeroen J M A Hendrikx, and Erik de Blois. 2022. “Radiolabeling and Quality Control of Therapeutic Radiopharmaceuticals: Optimization, Clinical Implementation and Comparison of Radio-TLC/HPLC Analysis, Demonstrated by [ 177 Lu]Lu-PSMA.” EJNMMI Radiopharmacy and Chemistry 7 (1): 29. doi:10.1186/s41181-022-00181-0.